Predictions
Advanced Micro Devices Inc.
Start price
Target price
Perf. (%)
€94.45
22.08.22
22.08.22
-
22.09.22
22.09.22
-5.58%
30.08.22
30.08.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Revenue growth >5% per year expected
Advanced Micro Devices Inc.
Start price
Target price
Perf. (%)
€94.45
22.08.22
22.08.22
-
22.09.22
22.09.22
-5.58%
30.08.22
30.08.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Revenue growth >5% per year expected
Advanced Micro Devices Inc.
Start price
Target price
Perf. (%)
€94.45
22.08.22
22.08.22
-
22.09.22
22.09.22
-5.58%
30.08.22
30.08.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Revenue growth >5% per year expected
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€36.50
22.08.22
22.08.22
€66.00
22.08.23
22.08.23
-8.22%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€25.58
22.08.22
22.08.22
€44.00
22.08.23
22.08.23
-5.00%
03.09.22
03.09.22
Could be very worthwhile Investment >20% year
Capable Management
Good culture
Innovative
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€64.74
22.08.22
22.08.22
€80.00
22.08.23
22.08.23
8.80%
23.08.23
23.08.23
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€64.74
22.08.22
22.08.22
€80.00
22.08.23
22.08.23
8.80%
23.08.23
23.08.23
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€64.74
22.08.22
22.08.22
€80.00
22.08.23
22.08.23
8.80%
23.08.23
23.08.23
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Toshiba Corp.
Start price
Target price
Perf. (%)
€38.14
22.08.22
22.08.22
€32.00
22.08.23
22.08.23
-24.23%
23.08.23
23.08.23
Probably not worthwhile Investment
EBIT decline/stagnation expected
Toshiba Corp.
Start price
Target price
Perf. (%)
€38.14
22.08.22
22.08.22
€32.00
22.08.23
22.08.23
-24.23%
23.08.23
23.08.23
Probably not worthwhile Investment
EBIT decline/stagnation expected
Toshiba Corp.
Start price
Target price
Perf. (%)
€38.14
22.08.22
22.08.22
€32.00
22.08.23
22.08.23
-24.23%
23.08.23
23.08.23
Probably not worthwhile Investment
EBIT decline/stagnation expected
Toshiba Corp.
Start price
Target price
Perf. (%)
€38.14
22.08.22
22.08.22
€32.00
22.08.23
22.08.23
-24.23%
23.08.23
23.08.23
Probably not worthwhile Investment
EBIT decline/stagnation expected
Mediwound Ltd.
Start price
Target price
Perf. (%)
€1.99
22.08.22
22.08.22
-
22.08.23
22.08.23
-7.04%
04.09.22
04.09.22
Could be very worthwhile Investment >20% year
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€9.88
22.08.22
22.08.22
€14.00
22.08.23
22.08.23
-17.77%
03.09.22
03.09.22
Capable Management
Good culture
Could be worthwhile Investment >10% per year
Little innovation
Mediwound Ltd.
Start price
Target price
Perf. (%)
€1.99
22.08.22
22.08.22
€4.00
22.08.23
22.08.23
-7.04%
04.09.22
04.09.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€10.10
22.08.22
22.08.22
€10.00
22.08.23
22.08.23
-13.85%
23.08.22
23.08.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Bank of America Corp.
Start price
Target price
Perf. (%)
€35.10
21.08.22
21.08.22
-
21.08.23
21.08.23
-23.75%
21.08.23
21.08.23
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€10.10
21.08.22
21.08.22
-
21.08.23
21.08.23
-99.29%
22.08.23
22.08.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€76.50
21.08.22
21.08.22
€230.00
21.08.23
21.08.23
6.54%
04.09.22
04.09.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€214.90
21.08.22
21.08.22
€87.00
21.08.23
21.08.23
-3.44%
04.09.22
04.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Home Depot Inc.
Start price
Target price
Perf. (%)
€321.00
20.08.22
20.08.22
-
20.08.23
20.08.23
-6.60%
21.08.23
21.08.23
Fair valuation
High dividend yield expected
Valuable balance sheet
Little Investments for future growth
Home Depot Inc.
Start price
Target price
Perf. (%)
€321.00
20.08.22
20.08.22
-
20.08.23
20.08.23
-6.60%
21.08.23
21.08.23
Fair valuation
High dividend yield expected
Valuable balance sheet
Little Investments for future growth